These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 5040633)

  • 1. Partial suppression of experimental allergic encephalomyelitis with heparin.
    Chelmicka-Szorc E; Arnason BG
    Arch Neurol; 1972 Aug; 27(2):153-8. PubMed ID: 5040633
    [No Abstract]   [Full Text] [Related]  

  • 2. [Immunological reactions and problems of immunosuppression in experimental and clinical forms of demyelinating diseases].
    Cendrowski W
    Neurol Neurochir Pol; 1971; 5(2):133-6. PubMed ID: 5576472
    [No Abstract]   [Full Text] [Related]  

  • 3. Drugs of abuse and experimental autoimmune diseases.
    Lyman WD
    Adv Exp Med Biol; 1991; 288():81-92. PubMed ID: 1659140
    [No Abstract]   [Full Text] [Related]  

  • 4. Experimental autoimmune demyelinating diseases: experimental allergic encephalomyelitis and experimental allergic neuritis.
    Lisak RP; Behan PO
    Biomedicine; 1975 Mar; 22(2):81-7. PubMed ID: 55276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Study of the specific and nonspecific effects on the development of experimental allergic encephalomyelitis].
    Zhitnukhin IuL
    Vestn Akad Med Nauk SSSR; 1974; (11):49-53. PubMed ID: 4450723
    [No Abstract]   [Full Text] [Related]  

  • 6. Relationship of experimental allergic encephalomyelitis to human disease.
    Levine S
    Res Publ Assoc Res Nerv Ment Dis; 1971; 49():33-49. PubMed ID: 5002492
    [No Abstract]   [Full Text] [Related]  

  • 7. Experimental allergic encephalomyelitis. V. Therapeutic attempts with immunosuppressive and antiinflammatory drugs.
    Anghelescu N; Petrescu A; Chimion D
    Neurol Psychiatr (Bucur); 1979; 17(2):99-105. PubMed ID: 482840
    [No Abstract]   [Full Text] [Related]  

  • 8. [Experimental allergic encephalomyelitis as model of a neuro-allergic disease].
    Hitzschke B; Meyer-Rienecker H; Sayk J; Schröter P
    Z Arztl Fortbild (Jena); 1969 Dec; 63(24):1315-20. PubMed ID: 5403442
    [No Abstract]   [Full Text] [Related]  

  • 9. Antilymphocyte serum in the later stages of experimental allergic encephalomyelitis.
    Leibowitz S; Kennedy LA; Lessof MH
    Lancet; 1968 Mar; 1(7542):569-70. PubMed ID: 4170277
    [No Abstract]   [Full Text] [Related]  

  • 10. Acute allergic encephalomyelitis (EAE) in the rat with special reference to immunologic and demyelinization effects.
    Piliero SJ; Cremonese P
    J Reticuloendothel Soc; 1973 Jul; 14(1):100-18. PubMed ID: 4126715
    [No Abstract]   [Full Text] [Related]  

  • 11. Suppression of experimental allergic encephalomyelitis by NSC 82196, a new imidazole carboxamide derivative.
    Vogel CL; De Vita VT; Lisak RP; Kies MW
    Cancer Res; 1969 Dec; 29(12):2249-53. PubMed ID: 5369677
    [No Abstract]   [Full Text] [Related]  

  • 12. Prolonged suppression of experimental allergic encephalomyelitis in the Lewis rats: the effect of lipopolysaccharides.
    Raziuddin S; Morrison DC
    J Immunol; 1982 Mar; 128(3):1486-9. PubMed ID: 6173441
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Experimental allergic encephalomyelitis: suppression with SD-170, a new synthetic drug.
    Kasckow JW; Tabira T; Itoyama Y; Kuroiwa Y; Takenaka A; Nagai Y
    Jpn J Exp Med; 1981 Oct; 51(5):293-8. PubMed ID: 6172610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunopathology of allergic encephalomyelitis.
    Brosnan CF; Wisniewski HM
    Prog Clin Biol Res; 1980; 39():379-90. PubMed ID: 7403188
    [No Abstract]   [Full Text] [Related]  

  • 15. The effect of anti-lymphocyte serum on experimental allergic encephalomyelitis in the guinea-pig.
    Leibowitz S; Lessof MH; Kennedy LA
    Clin Exp Immunol; 1968 Oct; 3(8):753-60. PubMed ID: 5718501
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppressor cell control of unresponsiveness to experimental allergic encephalomyelitis.
    Swierkosz JE; Swanborg RH
    J Immunol; 1975 Sep; 115(3):631-3. PubMed ID: 50370
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Experimental allergic encephalomyelitis. A review.
    Rowe MJ
    Bull Los Angeles Neurol Soc; 1969 Jan; 34(1):55-66. PubMed ID: 4974423
    [No Abstract]   [Full Text] [Related]  

  • 18. Another chance for thalidomide?
    Vladutiu A
    Lancet; 1966 Apr; 1(7444):981-2. PubMed ID: 4160655
    [No Abstract]   [Full Text] [Related]  

  • 19. [Experimental prevention and suppression of neuroallergic diseases].
    Hitzschke B; Meyer-Rienecker HJ; Günther J
    Psychiatr Neurol Med Psychol Beih; 1975; 20-21():17-22. PubMed ID: 829617
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of heterologous antilymphocyte serum on experimental allergic encephalomyelitis].
    Land W; Frick E; Roscher R; Brendel W; Baethmann A
    Klin Wochenschr; 1969 Jun; 47(12):633-40. PubMed ID: 5382544
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.